Positive Analyst Ratings Indicate Potential ETF Upside

Analysts see a significant upside for the iShares MSCI USA Min Vol Factor ETF (USMV), with an expected increase of 11.03% to $104.17. Notable holdings like Alnylam Pharmaceuticals (ALNY), Lilly (LLY), and Keurig Dr Pepper (KDP) show favorable potential price targets.

Date: 10-03-2025

AI Rating: 7

Potential Upside for ETFs
This report analyzes the iShares MSCI USA Min Vol Factor ETF (USMV) and its underlying holdings. The ETF's current trading price is $93.82, with a projected analyst target price of $104.17, indicating a potential upside of 11.03%.

Focusing on the underlying companies:

Alnylam Pharmaceuticals Inc (ALNY): Recent price is $244.52, with a target price of $309.08, showing a 26.40% upside.
Lilly (Eli) & Co (LLY): Trading at $869.58, anticipated to rise to $1018.09, representing a 17.08% upside.
Keurig Dr Pepper Inc (KDP): Current price is $33.34, expected to reach $38.28, which is a 14.81% increase.

Overall, the optimism about the future of USMV and its components could influence investor sentiment positively. However, questions remain regarding whether analysts are justified in their targets or if they may risk downgrading them later, depending on company developments.

Stocks: USMV ALNY LLY KDP